This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

VCA Antech's Management Presents At Bank Of America Merrill Lynch Health Care Conference (Transcript)

VCA Antech, Inc. (WOOF)

Bank of America Merrill Lynch Health Care Conference Call

May 17, 2012 14:20 ET

Executives

Tom Fuller – Chief Financial Officer

Jeff Framer – Corporate Controller

Analysts

Erin Wilson – Bank of America

Bob Willoughby – Bank of America

Presentation

Erin Wilson – Bank of America

….services team with Bob Willoughby. We are happy to have such a strong animal health contingent this year at the Bank of America Merrill Lynch Health Care Conference. Up next, we have VCA Antech, the leading animal hospital chain and leader of what we’d like to call the diagnostic sector.

And with that, I’ll hand it over to the Chief Financial Officer, Tom Fuller.

Tom Fuller

Thank you, Erin. I am Tom Fuller, the CFO of VCA. With me is Jeff Framer, who is actually our new Corporate Controller. And about six months ago I think Jeff has the – unfortunately he jumped into a company and spend the last six months at Vetstreet managing the financial side of that business, which is a great business that we’re behind schedule and we’re trying to achieve. But he’s doing a great job. So he is here today. As you take a moment to peruse our Safe Harbor disclosure, take a moment to reflect on what amazing company we have and what we’ve done. Just noticed one of our latest versions of the hat is 1986, which is actually, Bob’s asked me what that stands for, and that’s actually when we started the company, so we’re in our 25th year now. Look back what we’ve accomplished the past 25 years, it’s really transformative; invested in the industry, really created an industry.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 18,010.68 -115.44 -0.64%
S&P 500 2,107.39 -13.40 -0.63%
NASDAQ 5,070.0260 -27.95 -0.55%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs